Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
The injectable form is more prevalent and includes drugs such as liraglutide, exenatide, and semaglutide
Treatment plans are typically comprehensive and may include a combination of medication, physical therapy, and, in severe cases, surgery
Mads Krogsgaard Thomsen, at the time R&D executive in the Diabetes Care Division of Novo Nordisk, undertook the initiative to synthesize long-acting GLP-1 analogues (Fig
This updated strategy is tailored to address established cardiovascular disease, high cardiovascular risk, heart failure, kidney disease, or obesity [5, 6]
Blocks glucagon secretion: When your body needs to raise your blood sugar levels, it uses glucagon
Hypoglycaemia risk When used as monotherapy, GLP-1 receptor agonists carry minimal hypoglycaemia risk due to their glucose-dependent mechanism
US$ 27.37
US$ 28.97
US$ 27.92
US$ 28.56
US$ 29.23
US$ 28.22
